Secondary prevention trials in Alzheimer disease: The challenge of identifying a meaningful end point

Research output: Contribution to journalEditorial

19 Scopus citations
Original languageEnglish
Pages (from-to)947-949
Number of pages3
JournalJAMA Neurology
Volume71
Issue number8
DOIs
StatePublished - Aug 2014

Funding

FundersFunder number
National Institutes of Health (NIH)R01AG038651
National Institute on AgingP30AG028383

    ASJC Scopus subject areas

    • Clinical Neurology

    Fingerprint

    Dive into the research topics of 'Secondary prevention trials in Alzheimer disease: The challenge of identifying a meaningful end point'. Together they form a unique fingerprint.

    Cite this